Trajectories of Kidney Function in Autosomal Dominant Polycystic Kidney Disease Patients Treated with Tolvaptan
<i>Background and Objectives:</i> Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic kidney disease, and the only approved pharmacological therapy shown to slow disease progression is tolvaptan. This study presents a long-term observation of ADPKD patients treated at o...
Na minha lista:
| Principais autores: | , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
MDPI AG
2026-01-01
|
| 丛编: | Medicina |
| 主题: | |
| 在线阅读: | https://www.mdpi.com/1648-9144/62/1/194 |
| 标签: |
没有标签, 成为第一个标记此记录!
|